(provided by candidate): This proposal is submitted to seek funding to support additional protected time for Dr. Naga Chalasani so that he can dedicate his efforts to continue his own patient-oriented research and to provide mentorship for the new and junior investigators. Dr. Chalasani has a proven track record in patient-oriented research with more than 50 peer-reviewed publications and strong extramural funding. He has a successful record in mentoring GI/Hepatology (Gl) and Clinical Pharmacology fellows to conduct patient-oriented research in the area of clinical pharmacology aspects of liver disease. Heavy clinical responsibilities are limiting his ability to keep focused on his research and mentorship goals. If funded, this award will protect his time and help him sustain the momentum and productivity he has generated. His research goal is to become a senior investigator in patient-oriented research related to non-alcoholic steatohepatitis (NASH) and the relationship between cytochrome P450 enzymes (CYPs) and liver disease. During the funding period, the candidate will conduct the following patient-oriented research studies: (1) Studies stemming from the NASH Clinical Research Network which is funded by the NIDDK, (2) Studies stemming from the Hepatotoxicity Clinical Research Network which is funded by the NIDDK, (3) Studies stemming from the grant """"""""Effect of Cirrhosis and shunts on drug disposition"""""""" which is funded by the NIDDK, and (4) Studies stemming from the grant """"""""Pathogenesis of Non-alcoholic steatohepatitis"""""""" which was submitted to NIH for funding. The last set of translational studies will evaluate the role of altered CYPs in the pathogenesis of NASH in adults and children. His mentorship goal is to mentor the interested fellows and junior faculty to conduct patient-oriented research in the area of chronic liver disease as it relates to cytochrome P450 enzymes. The sources for the candidates to be mentored by Dr. Chalasani include adult and pediatric Gl fellows and junior faculty, Clinical Pharmacology fellows and the trainees enrolled in the Indiana University's Clinical Investigator Training Enhancement (CITE) Program. His mentoring plans are (1) to provide methodological and content assistance to the trainees, (2) to provide guidance related to regulatory aid compliance aspects of the patient-oriented research, (3) to provide protocol-specific opportunities for the trainees to get directly involved in patient-oriented research, (4) to provide on-and off-campus learning resources to enhance their ability to conduct patient-oriented research, and (5) to provide assistance with grant submission for intra-and extramural funding and publication of their research findings.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Midcareer Investigator Award in Patient-Oriented Research (K24)
Project #
1K24DK069290-01A1
Application #
6965245
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Podskalny, Judith M,
Project Start
2005-09-30
Project End
2010-08-31
Budget Start
2005-09-30
Budget End
2006-08-31
Support Year
1
Fiscal Year
2005
Total Cost
$126,840
Indirect Cost
Name
Indiana University-Purdue University at Indianapolis
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
603007902
City
Indianapolis
State
IN
Country
United States
Zip Code
46202
Liang, Tiebing; Chalasani, Naga P; Williams, Kent Edward et al. (2017) Differential Expression of miRNAs in Nontumor Liver Tissue of Patients With Hepatocellular Cancer Caused by Nonalcoholic Steatohepatitis Cirrhosis. Clin Gastroenterol Hepatol 15:465-467
Ghabril, Marwan; Jackson, Mollie; Gotur, Raghavender et al. (2017) Most Individuals With Advanced Cirrhosis Have Sleep Disturbances, Which Are Associated With Poor Quality of Life. Clin Gastroenterol Hepatol 15:1271-1278.e6
Carr, Rotonya M; Dhir, Ravindra; Mahadev, Kalyankar et al. (2017) Perilipin Staining Distinguishes Between Steatosis and Nonalcoholic Steatohepatitis in Adults and Children. Clin Gastroenterol Hepatol 15:145-147
Fisher, Marisa M; Watkins, Renecia A; Blum, Janice et al. (2015) Elevations in Circulating Methylated and Unmethylated Preproinsulin DNA in New-Onset Type 1 Diabetes. Diabetes 64:3867-72
Masuoka, Howard C; Vuppalanchi, Raj; Deppe, Ross et al. (2015) Individuals with Primary Sclerosing Cholangitis Have Elevated Levels of Biomarkers for Apoptosis but Not Necrosis. Dig Dis Sci 60:3642-6
Bell, Lauren N; Wulff, Jacob; Comerford, Megan et al. (2015) Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis. Liver Int 35:263-74
Vuppalanchi, Raj; Gotur, Raghavender; Reddy, K Rajender et al. (2014) Relationship between characteristics of medications and drug-induced liver disease phenotype and outcome. Clin Gastroenterol Hepatol 12:1550-5
Sozio, Margaret S; Chalasani, Naga (2014) Activated recombinant factor VIIa should not be used in patients with refractory variceal bleeding: it is mostly ineffective, is expensive, and may rarely cause serious adverse events. Hepatology 60:1786-8
Corey, Kathleen E; Chalasani, Naga (2014) Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 12:1077-84; quiz e59-60
Vuppalanchi, Raj; Troutt, Jason S; Konrad, Robert J et al. (2014) Serum hepcidin levels are associated with obesity but not liver disease. Obesity (Silver Spring) 22:836-41

Showing the most recent 10 out of 60 publications